Covered recipient · General Payments record
MARTIN B ENGELHARDT
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2022
$3,712.24
- Reported across 183 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2022 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $405.54 | 17 |
By paying entity
PY2022 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $238.38 | 10 |
| GlaxoSmithKline, LLC. | $97.89 | 4 |
| Sunovion Pharmaceuticals Inc. | $30.19 | 1 |
| Amneal Pharmaceuticals LLC | $21.51 | 1 |
| Acerta Pharma LLC | $17.57 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2022 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $25.90 | 01/10/2022 | Food and Beverage | Undisputed | 01/23/2026 | 890922973 | CMS |
| ABBVIE INC. | $21.42 | 02/01/2022 | Food and Beverage | Undisputed | 01/23/2026 | 890922975 | CMS |
| ABBVIE INC. | $23.05 | 03/02/2022 | Food and Beverage | Undisputed | 01/23/2026 | 890922977 | CMS |
| ABBVIE INC. | $21.39 | 04/06/2022 | Food and Beverage | Undisputed | 01/23/2026 | 890922979 | CMS |
| ABBVIE INC. | $26.04 | 05/04/2022 | Food and Beverage | Undisputed | 01/23/2026 | 890922981 | CMS |
| ABBVIE INC. | $30.00 | 05/23/2022 | Food and Beverage | Undisputed | 01/23/2026 | 890922983 | CMS |
| ABBVIE INC. | $23.03 | 07/06/2022 | Food and Beverage | Undisputed | 01/23/2026 | 890922985 | CMS |
| ABBVIE INC. | $16.22 | 08/10/2022 | Food and Beverage | Undisputed | 01/23/2026 | 890922987 | CMS |
| ABBVIE INC. | $29.94 | 09/07/2022 | Food and Beverage | Undisputed | 01/23/2026 | 890922989 | CMS |
| ABBVIE INC. | $21.39 | 10/26/2022 | Food and Beverage | Undisputed | 01/23/2026 | 890922991 | CMS |
| Amneal Pharmaceuticals LLC | $21.51 | 06/15/2022 | Food and Beverage | Undisputed | 01/23/2026 | 956578359 | CMS |
| AstraZeneca Pharmaceuticals LP | $17.57 | 02/17/2022 | Food and Beverage | Undisputed | 01/23/2026 | 915829589 | CMS |
| GlaxoSmithKline, LLC. | $32.49 | 06/02/2022 | Food and Beverage | Undisputed | 01/23/2026 | 944816721 | CMS |
| GlaxoSmithKline, LLC. | $17.21 | 09/01/2022 | Food and Beverage | Undisputed | 01/23/2026 | 944816715 | CMS |
| GlaxoSmithKline, LLC. | $34.66 | 10/04/2022 | Food and Beverage | Undisputed | 01/23/2026 | 944816719 | CMS |
| GlaxoSmithKline, LLC. | $13.53 | 11/03/2022 | Food and Beverage | Undisputed | 01/23/2026 | 944816717 | CMS |
| Sunovion Pharmaceuticals Inc. | $30.19 | 06/29/2022 | Food and Beverage | Undisputed | 01/23/2026 | 920942589 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022
- Generated from
- OP_DTL_GNRL_PGYR2022_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.